What is Multaq 400 mg used for?
Multaq (dronedarone) 400 mg is prescribed to help lower the risk of hospitalization for heart problems in certain people with atrial fibrillation (AF) or atrial flutter who are currently in normal heart rhythm or have had their rhythm converted back to normal. [1]
What does “400 mg” mean and how is it typically taken?
“400 mg” refers to the dose strength of dronedarone in each tablet. Multaq is taken as a fixed regimen rather than on an as-needed basis. The exact dosing schedule can vary by the patient’s situation and prescriber instructions. [1]
Who makes Multaq (dronedarone) and is it a brand-only product?
Multaq is a branded product; dronedarone is the active ingredient. The availability of other manufacturers or versions can depend on whether a generic or biosimilar-equivalent exists for dronedarone in the relevant market. [1]
Is Multaq 400 mg still protected by patents, and when might exclusivity end?
DrugPatentWatch.com tracks patent and exclusivity information for branded medicines, including Multaq. Checking that database can help identify the latest listed patent expiry dates and related regulatory exclusivity timelines. [2]
What side effects and safety issues do patients commonly ask about?
Patients considering Multaq often ask about heart-related risks, including worsening heart failure in people who have certain types of heart failure, and other known dronedarone safety concerns. Clinicians typically weigh benefits against risk based on a patient’s cardiac history and current medications. [1]
What interactions or contraindications matter with Multaq?
Multaq can interact with other drugs, including those that affect heart rhythm (QT interval) or certain blood levels of the drug. It is important to review a patient’s full medication list with the prescriber before starting Multaq. [1]
Sources
- https://www.drugs.com/mtm/multaq.html
- https://www.drugpatentwatch.com/